| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
802 |
| issn |
1178-203X |
| issueIdentifier |
4 |
| pageRange |
797-802 |
| publicationName |
Therapeutics and Clinical Risk Management |
| startingPage |
797 |
| bibliographicCitation |
Tillmann HL. The treatment of chronic hepatitis B: Focus on adefovir-like antivirals. Ther Clin Risk Manag. 2008 Aug;4(4):797–802. PMID: 19209262; PMCID: PMC2621388. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08e905bd6d50c919dd17600eb729fbca |
| date |
200808 |
| identifier |
https://doi.org/10.2147/tcrm.s1965
https://pubmed.ncbi.nlm.nih.gov/PMC2621388
https://pubmed.ncbi.nlm.nih.gov/19209262 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1178-203X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159269
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 |